Skip to main content

Advertisement

Table 2 Surgical management and postoperative outcome

From: Vitreous haemorrhage in massive hemorrhagic polypoidal choroidal vasculopathy: clinical characteristics and surgical outcomes

1. Baseline BCVA at presentation 2.69 ± 0.57 (<20/2000)
2. BCVA at 1 months postoperative visit improvement from baseline 1.65 (SD 0.93, 20/800, p = 0.001), range 20/20 to no PL, 0.99 logMAR units, (p = < 0.001, 95 % CI 0.64–1.34)
3. BCVA at 6 months postoperative visit 1.53 (SD 1.2, 20/600, p = 0.0001), range 20/20 to no PL
4. Improvement from baseline to last visit 0.96 logMAR units, (p < 0.0001, 95 % CI 0.54–1.37)
5. Mean follow up 14.8 months (range 1–84 months)
6. BCVA improved by two lines or more than presenting VA at last follow up 16 of 28 eyes (57.1 %)
7. BCVA worsened at last follow up than baseline BCVA 3 of 28 eyes (10.7 %)
8. Complications Cataract (n = 10), macular scar (n = 4), organised dehemoglobinised blood/exudates (n = 7), retinal detachment (n = 5), iatrogenic retinal breaks (n = 5), recurrent VH (n = 3), choroidal detachment (n = 1)
  1. BCVA best-corrected visual acuity, PL perception of light, VH vitreous hemorrhage